UK News Archive

The UK News Archive contains resources intended for journalists only.

2021

February

Media Release / Feb 12, 2021

Novartis signs initial agreement to provide manufacturing capacity for Pfizer-BioNTech COVID-19 vaccine

Read More
Media Release / Feb 03, 2021

NICE issues final guidance recommending Novartis’ novel eye treatment Beovu® (brolucizumab) as an option for wet age-related macular degeneration

Read More

January

Media Release / Jan 29, 2021

Novartis receives positive CHMP opinion for Kesimpta® (ofatumumab), a self-administered treatment for adult patients with relapsing multiple sclerosis with active disease

Read More
Story / Jan 29, 2021

Novartis UK awarded Top Employer status for eighth consecutive year

Read More
Media Release / Jan 25, 2021

Novartis UK Estradot supplies statement

Read More
2020

December

Media Release / Dec 11, 2020

Aimovig® (erenumab) NICE Final Appraisal Document (FAD) publication – Novartis UK media statement

Read More

November

Story / Nov 17, 2020

Novartis walks-the-talk with the Red Shoe Movement

Read More

October

Media Release / Oct 15, 2020

Novartis’ Mayzent®▼ (siponimod) becomes the first oral treatment recommended by NICE and SMC for adults living with secondary progressive multiple sclerosis (SPMS) with active disease

Read More
Media Release / Oct 12, 2020

Novartis’ Mayzent®▼ (siponimod) receives approval from the Scottish Medicines Consortium as the first recommended treatment in Scotland for patients living with secondary progressive multiple sclerosis (SPMS) with active disease

Read More

September

Media Release / Sep 22, 2020

Tomorrow Transformed

Read More

Related Links